Olema Pharmaceuticals Inc (NASDAQ: OLMA) kicked off on Tuesday, up 5.83% from the previous trading day, before settling in for the closing price of $4.80. Over the past 52 weeks, OLMA has traded in a range of $2.86-$16.62.
Here's Your FREE Report on the #1 Small-Cap Uranium Stock of '24.
Small-cap Uranium stocks are booming in 2024! The company we're about to show you is the ONLY small-cap stock in the space that benefits from ALL aspects of the global Uranium industry with none of the risks of running a mine. Smart investors will not be hesitating on this one!
Get the FREE Report with all the details here.
Sponsored
While this was happening, its average annual earnings per share was recorded 19.90%. With a float of $52.12 million, this company’s outstanding shares have now reached $68.33 million.
Let’s determine the extent of company efficiency that accounts for 96 employees. In terms of profitability, gross margin is 0.0%, operating margin of 0.0%, and the pretax margin is 0.0%.
Olema Pharmaceuticals Inc (OLMA) Breakdown of a Key Holders of the stock
Our next focus will be how large-scale investors are participating in this stock of the Biotechnology Industry. The insider ownership of Olema Pharmaceuticals Inc is 23.83%, while institutional ownership is 77.89%. The most recent insider transaction that took place on Jan 08 ’25, was worth 1,727,370. In this transaction 10% Owner of this company bought 300,000 shares at a rate of $5.76, taking the stock ownership to the 7,800,000 shares. Before that another transaction happened on Dec 17 ’24, when Company’s Director sold 700,761 for $6.75, making the entire transaction worth $4,730,137. This insider now owns 0 shares in total.
Olema Pharmaceuticals Inc (OLMA) Recent Fiscal highlights
According to the Wall Street analysts, stocks earnings will be around 19.90% per share during the next fiscal year. For the long-term projections, market analysts anticipate that the company’s EPS will surge by 6.25% during the next five years compared to -83.00% drop over the previous five years of trading.
Olema Pharmaceuticals Inc (NASDAQ: OLMA) Trading Performance Indicators
Take a look at Olema Pharmaceuticals Inc’s (OLMA) current performance indicators. Last quarter, stock had a quick ratio of 15.22.
For the trailing twelve months, Company’s Diluted EPS (Earnings per Share) is -1.95, a number that is poised to hit -0.38 in the next quarter and is forecasted to reach -1.94 in one year’s time.
Technical Analysis of Olema Pharmaceuticals Inc (OLMA)
Looking closely at Olema Pharmaceuticals Inc (NASDAQ: OLMA), its last 5-days average volume was 0.56 million, which is a drop from its year-to-date volume of 1.0 million. As of the previous 9 days, the stock’s Stochastic %D was 70.42%. Additionally, its Average True Range was 0.40.
During the past 100 days, Olema Pharmaceuticals Inc’s (OLMA) raw stochastic average was set at 57.78%, which indicates a significant decrease from 60.90% during the past two weeks. Based on volatility metrics of the stock, it showed a historical volatility of 93.86% in the past 14 days, which was higher than the 77.76% volatility it showed in the past 100 days.
At the time of writing, stock’s 50-day Moving Average is $4.36, while its 200-day Moving Average is $8.01. However, in the short run, Olema Pharmaceuticals Inc’s stock first resistance to watch stands at $5.19. Second resistance stands at $5.29. The third major resistance level sits at $5.49. If the price goes on to break the first support level at $4.89, it is likely to go to the next support level at $4.69. Now, if the price goes above the second support level, the third support stands at $4.59.
Olema Pharmaceuticals Inc (NASDAQ: OLMA) Key Stats
The company with the Market Capitalisation of 347.58 million has total of 68,421K Shares Outstanding. Its annual sales at the moment are 0 K in contrast with the sum of -129,470 K annual income. Company’s last quarter sales were recorded 0 K and last quarter income was -30,390 K.
